报价延迟最少15分钟:2026/08/26 00:57 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
26.92 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.43/--
|
|
企业价值
1.62B
|
| 资产负债 |
|
每股账面净值
4.43
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
95.13M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions. |
